215 related articles for article (PubMed ID: 28821955)
21. Pathomic Features Reveal Immune and Molecular Evolution From Lung Preneoplasia to Invasive Adenocarcinoma.
Chen P; Rojas FR; Hu X; Serrano A; Zhu B; Chen H; Hong L; Bandyoyadhyay R; Aminu M; Kalhor N; Lee JJ; El Hussein S; Khoury JD; Pass HI; Moreira AL; Velcheti V; Sterman DH; Fukuoka J; Tabata K; Su D; Ying L; Gibbons DL; Heymach JV; Wistuba II; Fujimoto J; Solis Soto LM; Zhang J; Wu J
Mod Pathol; 2023 Dec; 36(12):100326. PubMed ID: 37678674
[TBL] [Abstract][Full Text] [Related]
22. Expression Changes in Programmed Death Ligand 1 from Precancerous Lesions to Invasive Adenocarcinoma in Subcentimeter Pulmonary Nodules: A Large Study of 2022 Cases in China.
Yang X; Xiao Y; Hu H; Qiu ZB; Qi YF; Wang MM; Wu YL; Zhong WZ
Ann Surg Oncol; 2023 Nov; 30(12):7400-7411. PubMed ID: 37658270
[TBL] [Abstract][Full Text] [Related]
23. Pulmonary preinvasive neoplasia.
Kerr KM
J Clin Pathol; 2001 Apr; 54(4):257-71. PubMed ID: 11304841
[TBL] [Abstract][Full Text] [Related]
24. Genomic landscape of allelic imbalance in premalignant atypical adenomatous hyperplasias of the lung.
Sivakumar S; San Lucas FA; Jakubek YA; McDowell TL; Lang W; Kallsen N; Peyton S; Davies GE; Fukuoka J; Yatabe Y; Zhang J; Futreal PA; Fowler J; Fujimoto J; Ehli EA; Hawk ET; Wistuba II; Kadara H; Scheet P
EBioMedicine; 2019 Apr; 42():296-303. PubMed ID: 30905849
[TBL] [Abstract][Full Text] [Related]
25. Increased expressions of claudin 4 and 7 in atypical adenomatous hyperplasia and adenocarcinoma of the lung.
Yamada G; Murata M; Takasawa A; Nojima M; Mori Y; Sawada N; Takahashi H
Med Mol Morphol; 2016 Sep; 49(3):163-9. PubMed ID: 26872891
[TBL] [Abstract][Full Text] [Related]
26. Proliferative activity, p53 expression and loss of heterozygosity on 3p, 9p and 17p in atypical adenomatous hyperplasia of the lung.
Kitaguchi S; Takeshima Y; Nishisaka T; Inai K
Hiroshima J Med Sci; 1998 Mar; 47(1):17-25. PubMed ID: 9583279
[TBL] [Abstract][Full Text] [Related]
27. Correlation between genetic alterations and histopathological subtypes in bronchiolo-alveolar carcinoma and atypical adenomatous hyperplasia of the lung.
Yamasaki M; Takeshima Y; Fujii S; Kitaguchi S; Matsuura M; Tagawa K; Inai K
Pathol Int; 2000 Oct; 50(10):778-85. PubMed ID: 11107049
[TBL] [Abstract][Full Text] [Related]
28. Genomic Landscape and Immune Microenvironment Features of Preinvasive and Early Invasive Lung Adenocarcinoma.
Zhang C; Zhang J; Xu FP; Wang YG; Xie Z; Su J; Dong S; Nie Q; Shao Y; Zhou Q; Yang JJ; Yang XN; Zhang XC; Li Z; Wu YL; Zhong WZ
J Thorac Oncol; 2019 Nov; 14(11):1912-1923. PubMed ID: 31446140
[TBL] [Abstract][Full Text] [Related]
29. Analysis of pre-invasive lung adenocarcinoma lesions on thin-section computerized tomography.
Xing Y; Li Z; Jiang S; Xiang W; Sun X
Clin Respir J; 2015 Jul; 9(3):289-96. PubMed ID: 24720643
[TBL] [Abstract][Full Text] [Related]
30. The pattern of K-ras mutation in pulmonary adenocarcinoma defines a new pathway of tumour development in the human lung.
Cooper CA; Carby FA; Bubb VJ; Lamb D; Kerr KM; Wyllie AH
J Pathol; 1997 Apr; 181(4):401-4. PubMed ID: 9196437
[TBL] [Abstract][Full Text] [Related]
31. The association between atypical adenomatous hyperplasia and primary lung cancer.
Chapman AD; Kerr KM
Br J Cancer; 2000 Sep; 83(5):632-6. PubMed ID: 10944604
[TBL] [Abstract][Full Text] [Related]
32. The value of CT attenuation in distinguishing atypical adenomatous hyperplasia from adenocarcinoma in situ.
Jiang B; Wang J; Jia P; Le M
Zhongguo Fei Ai Za Zhi; 2013 Nov; 16(11):579-83. PubMed ID: 24229623
[TBL] [Abstract][Full Text] [Related]
33. Bronchioloalveolar neoplasia.
Kitamura H; Okudela K
Int J Clin Exp Pathol; 2010 Nov; 4(1):97-9. PubMed ID: 21228931
[TBL] [Abstract][Full Text] [Related]
34. Expressions of ATF6, XBP1, and GRP78 in normal tissue, atypical adenomatous hyperplasia, and adenocarcinoma of the lung.
Ogata S; Kameda K; Kono T; Ozeki Y; Hashimoto H; Tominaga S; Nakanishi K
Hum Pathol; 2019 Jan; 83():22-28. PubMed ID: 30121368
[TBL] [Abstract][Full Text] [Related]
35. Epidermal growth factor receptor mutation and pathologic-radiologic correlation between multiple lung nodules with ground-glass opacity differentiates multicentric origin from intrapulmonary spread.
Chung JH; Choe G; Jheon S; Sung SW; Kim TJ; Lee KW; Lee JH; Lee CT
J Thorac Oncol; 2009 Dec; 4(12):1490-5. PubMed ID: 19844187
[TBL] [Abstract][Full Text] [Related]
36. Targeted next-generation-sequencing for reliable detection of targetable rearrangements in lung adenocarcinoma-a single center retrospective study.
Velizheva NP; Rechsteiner MP; Valtcheva N; Freiberger SN; Wong CE; Vrugt B; Zhong Q; Wagner U; Moch H; Hillinger S; Schmitt-Opitz I; Soltermann A; Wild PJ; Tischler V
Pathol Res Pract; 2018 Apr; 214(4):572-578. PubMed ID: 29580750
[TBL] [Abstract][Full Text] [Related]
37. Mutations of the epidermal growth factor receptor gene in atypical adenomatous hyperplasia and bronchioloalveolar carcinoma of the lung.
Yoshida Y; Shibata T; Kokubu A; Tsuta K; Matsuno Y; Kanai Y; Asamura H; Tsuchiya R; Hirohashi S
Lung Cancer; 2005 Oct; 50(1):1-8. PubMed ID: 15950315
[TBL] [Abstract][Full Text] [Related]
38. Promoter hypermethylation of hallmark cancer genes in atypical adenomatous hyperplasia of the lung.
Licchesi JD; Westra WH; Hooker CM; Herman JG
Clin Cancer Res; 2008 May; 14(9):2570-8. PubMed ID: 18451218
[TBL] [Abstract][Full Text] [Related]
39. Correlation exploration among CT imaging, pathology and genotype of pulmonary ground-glass opacity.
Cai Y; Chen T; Zhang S; Tan M; Wang J
J Cell Mol Med; 2023 Jul; 27(14):2021-2031. PubMed ID: 37340599
[TBL] [Abstract][Full Text] [Related]
40. Is high-grade adenomatous hyperplasia an early bronchioloalveolar adenocarcinoma?
Ullmann R; Bongiovanni M; Halbwedl I; Fraire AE; Cagle PT; Mori M; Papotti M; Popper HH
J Pathol; 2003 Nov; 201(3):371-6. PubMed ID: 14595748
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
